|
|
||||||||
-Adrenergic receptor blockade impairs NO-dependent
dilation of large coronary arteries during exercise
Institut de Cardiologie de Montréal and Department of Physiology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada H1T 1C8
Shear stress-dependent
nitric oxide (NO) formation prevents immoderate vascular
constriction. We examined whether shear stress-dependent NO formation
limits exercise-induced coronary artery constriction after
-adrenergic receptor blockade in dogs. Control exercise led to
increases (P < 0.01) in coronary blood flow (CBF) by
38 ± 5 ml/min from 41 ± 5 ml/min and in the external
diameter of epicardial coronary arteries (CD) by 0.24 ± 0.03 mm
from 3.33 ± 0.20 mm. CD and shear stress were linearly related.
After propranolol, CD fell (P < 0.01) during exercise
(0.08 ± 0.03 from 3.23 ± 0.19 mm), and the slope of the
relationship between CD and shear stress was reduced (P < 0.01). This slope was not further altered by the additional blockade
of NO formation. In propranolol-treated resting dogs, flow-dependent
effects of intracoronary adenosine to mimic exercise-induced increases
in shear stress (after propranolol) led to increases (P < 0.01) in CD (0.09 ± 0.02 from 3.68 ± 0.27 mm). Thus both
shear stress-dependent NO formation and
-adrenergic receptor
activation are required to cause CD dilation during exercise. Suppression of
-adrenergic receptor activation leads to impaired shear stress-dependent NO formation and allows
-adrenergic
constriction to become dominant.
nitric oxide; adrenergic receptors; endothelium; shear stress; coronary vessels
This article has been cited by other articles:
![]() |
J. C. Poole, H. Snieder, H. C. Davis, and F. A. Treiber Anger suppression and adiposity modulate association between ADRB2 haplotype and cardiovascular stress reactivity. Psychosom Med, March 1, 2006; 68(2): 207 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Koksal, O. Uskudar, S. Koklu, O. Yuksel, Y. Beyazit, and B. Sahin Propranolol-Exacerbated Mesenteric Ischemia in a Patient with Hyperthyroidism Ann. Pharmacother., March 1, 2005; 39(3): 559 - 562. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |